Interpreting overdiagnosis estimates in population-based mammography screening - Wikidata - wikimedia - TriplyDB

Interpreting overdiagnosis estimates in population-based mammography screening

Interpreting overdiagnosis estimates in population-based mammography screening

http://www.wikidata.org/entity/Q34195837

about

Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods Overdiagnosis and overtreatment of prostate cancer The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.Women's views on overdiagnosis in breast cancer screening: a qualitative study.Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom Benefit-to-harm ratio of the Danish breast cancer screening programme.Cancer screening: the journey from epidemiology to policy.Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data.Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.Overdiagnosis: epidemiologic concepts and estimation.Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review.High sensitivity non-invasive detection of calcifications deep inside biological tissue using Transmission Raman Spectroscopy.Overdiagnosis in screening mammography in Denmark: population based cohort study Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.Which strategies reduce breast cancer mortality most? Collaborative modeling of optimal screening, treatment, and obesity prevention Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.Overdiagnosis among women attending a population-based mammography screening program.Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program Overdiagnosis in lung cancer screening: why modelling is essential Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts.Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.Mammographic screening detects low-risk tumor biology breast cancers.Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.Position paper: breast cancer screening, diagnosis, and treatment in Denmark.Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers?Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects.The UK breast screening program - what you need to know.The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.The Japanese Guidelines for Breast Cancer Screening.The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.

P2860

Q26824867-9C4E4A7B-7E40-4894-9A88-0468B9B6D9C7 Q26859596-56735318-9214-40E2-90E2-65F405C422AA Q27347267-7958026C-4A2E-4A84-B430-79D1A3467829 Q27347760-437576C0-402C-4E42-9E91-C7A5790DD880 Q30532790-219BAFC0-3B55-4CF4-AA6C-8793322AFA2B Q33613703-5A82E07C-AF6D-41B0-B27E-2C2DED42CCF8 Q33739409-A939DA09-8DED-49DB-9CD2-D3171C58CD0B Q33845856-B77478F6-BDBC-470A-8466-0682DAB867AF Q33897050-F54DFC66-9345-4439-A799-BD7A517B20DF Q33978331-0B54E14F-A5D7-4316-A515-9A1CA2698F22 Q34082491-9F90B540-2427-4353-8581-2B9DA0E74F91 Q34145175-87DB3181-7ABD-4B66-BBCF-E6C11B6CE176 Q34283688-3A830A30-CC27-456D-80C4-E4F8ACAA92F9 Q35438645-3EEF8301-A9B7-42BA-ADF6-AC3FB06755E6 Q35713073-103E1A5A-EC37-4871-84DF-BD2DE0305E99 Q35803986-55E07C63-E6D0-44AB-B819-3117A8ACD060 Q36276324-6EFE3382-013B-4044-B5D7-8CC3511EB0ED Q36411029-6FA2F656-C101-4674-B478-664D373C6825 Q36638777-F72EAD44-AAB2-473B-8AFF-0D7029F2A69F Q36770273-A6E73CEA-7861-47A1-A88E-370FD83B6A0F Q36887123-DD8E5F25-A7C2-477C-AA1B-3B15BC43E937 Q36980173-6D1AD6A6-9AAC-4151-82AE-36BC613D92A6 Q37001469-ECB52C6E-212C-44CF-A2AC-231074FE0E4F Q37001743-2F1E4F1D-B3A0-4715-940C-9F8EC4A99771 Q37070417-30C92F76-D99C-4320-B4A9-5E00ADBD08F4 Q37096178-4803C318-41CF-4832-8284-7F40F6429637 Q37116679-F06FCE3E-459D-46C2-A8A6-5F88CC5004A2 Q37162900-B615C7C1-74B6-4973-8DF1-B155F05DBD63 Q37279323-0288E920-8557-4947-A82B-B011F73FEB7D Q37353833-94A7499A-4E67-4A17-841C-7D1D68A3FA8D Q37583102-8FA23877-2A13-4EB5-A7E7-2EA5C439F949 Q37720423-D8A8E7D9-8241-4BC7-8688-BED7D8B9D6AB Q38042897-5F143626-7651-485F-8E86-A2F68B4BB7C4 Q38185110-F2D5BD5E-3573-4998-A86B-DFA1954CDBB1 Q38254913-424DFDC9-5C50-45ED-9A09-4BBB1F753D63 Q38415175-CDB84074-870B-4660-922C-2323A468A7EC Q38665126-030E2295-48ED-47E0-8FDC-98AC50A3D5EC Q38805542-D5B6E6B5-23BC-4CE1-8C41-C3341F96BDD4 Q38840507-14F131FD-C4F7-4277-B1EE-DDFFC02EEDCA Q38937235-64556A23-0E7C-4A99-9485-E9032C80D5BB

P2860

Interpreting overdiagnosis estimates in population-based mammography screening

http://www.wikidata.org/entity/Q34195837

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Interpreting overdiagnosis estimates in population-based mammography screening

@ast

Interpreting overdiagnosis estimates in population-based mammography screening

@en

Interpreting overdiagnosis estimates in population-based mammography screening

@nl

type

label

Interpreting overdiagnosis estimates in population-based mammography screening

@ast

Interpreting overdiagnosis estimates in population-based mammography screening

@en

Interpreting overdiagnosis estimates in population-based mammography screening

@nl

prefLabel

Interpreting overdiagnosis estimates in population-based mammography screening

@ast

Interpreting overdiagnosis estimates in population-based mammography screening

@en

Interpreting overdiagnosis estimates in population-based mammography screening

@nl

P1433

Q34195837-41C392F6-6E6F-4872-BE18-4A5653485FE3

P1476

Q34195837-44DB066F-F3C5-491F-A11F-03002EC48604

P2093

Q34195837-2E6E0F0E-64C7-474C-9350-9DD7F68C89FB

Q34195837-3F8A0C5F-39C3-4E2B-B220-95E3532162EE

Q34195837-56787AE8-1FE6-4EA9-8E75-DF20EAF2DC7C

Q34195837-8E312444-340E-4D5C-93AC-EB49DD8A8890

Q34195837-989D3C4C-D3FC-4444-996E-3E6991E6D5FB

Q34195837-D0C43C68-E340-4F4B-A5A3-049AD3E7B2A9

P275

Q34195837-8E398257-C5E0-4F15-9184-08B99E7068A2

P2860

Q34195837-1204D8CF-505E-408F-8825-7E000BF774C8

Q34195837-1D443DEC-4BC6-42A7-8FB7-AF0E8273B82C

Q34195837-25E770DF-46AC-4F6D-8713-7D230498349B

Q34195837-35ABE7F8-ACD0-4EA9-9169-9359A6AA6539

Q34195837-37FA651D-AF93-4331-8113-A5D261624E49

Q34195837-49ABE8AB-927E-4225-9C14-6FF228046AFC

Q34195837-5BB1FC90-9160-4654-AF0F-C4FC19695A6A

Q34195837-5DC4AF90-9306-4443-9BB3-F2C0B909063E

Q34195837-66F84053-B922-47E1-9D30-2D31BBE554B3

Q34195837-67E7CF73-CC4F-45F6-9644-9DAFAE9D2BFE

P304

Q34195837-DC9615D2-F3A4-40B8-86BB-203D7C0EFAA1

P31

Q34195837-42F8E8FA-0B2D-45B5-A2E7-1A2D928C7099

Q34195837-48D7D09D-2592-4690-8064-1A3D79A0096C

P356

Q34195837-3E3896B4-2502-4C28-8E9B-3D893DD599E3

P478

Q34195837-FC084CD6-A7E3-449B-8D63-705D2EE6F465

P5008

Q34195837-A686EB90-634A-4DA8-B258-BF85199B97D5

P577

Q34195837-09183100-01E4-4FAA-AB3D-6F9A266429C7

P5875

Q34195837-9DF2B206-F8C4-43E0-9D66-D026353FB9B2

P698

Q34195837-D1824984-C32B-4A36-9F94-B70BA8F3652C

P921

Q34195837-3C52F8E2-4F00-4E05-B364-CA90137FC357

Q34195837-860A8320-97AB-4121-B2CD-36CF4D72D5EA

Q34195837-A7F12A65-B947-4B79-875B-3C4D0CF95617

Q34195837-F499A517-471D-46CF-BBE8-8BA11FBF1F86

P932

Q34195837-4E672E3D-AA9D-42BE-8D40-A35F392C9992

P356

P1433

Epidemiologic Reviews

P1476

Interpreting overdiagnosis estimates in population-based mammography screening

@en

P2093

Eveline A M Heijnsdijk

http://www.w3.org/2001/XMLSchema#string

Gerrit Draisma

http://www.w3.org/2001/XMLSchema#string

Harry J de Koning

http://www.w3.org/2001/XMLSchema#string

Jacques Fracheboud

http://www.w3.org/2001/XMLSchema#string

Nicolien T van Ravesteyn

http://www.w3.org/2001/XMLSchema#string

Rianne de Gelder

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening.

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

Epidemiology of ductal carcinoma in situ

Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.

Overdiagnosis in organised mammography screening in Denmark. A comparative study.

Ductal carcinoma in situ. Implications for screening mammography.

Overdiagnosis in cancer.

Breast cancer incidence and overdiagnosis in Catalonia (Spain)

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.

P304

111-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EPIREV/MXR009

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51253615

http://www.w3.org/2001/XMLSchema#string

P698

21709144

http://www.w3.org/2001/XMLSchema#string

P921

breast neoplasm

preventive health services

biomedical investigative technique

P932

3132806

http://www.w3.org/2001/XMLSchema#string